Clinical Trial Update: Extension Study on Safety of Long-Term Growth Hormone Replacement in Adult Patients With Growth Hormone Deficiency [Phase 3]

View source ↗

Summary

Phase 3 extension study evaluating the safety of long-term growth hormone replacement in adults with growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• HUMATROPE (somatropin)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Adult Growth Hormone Deficiency | Phase 3 | Status: COMPLETED